Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

By Michael J. Pencina, Ewout W. Steyerberg, Ralph B. D’Agostino. Statistics in Medicine, 2010

2,465 citations recorded by the source corpus.

Appropriate quantification of added usefulness offered by new markers included in risk prediction algorithms is a problem of active research and debate. Standard methods, including statistical significance and c statistic are useful but not sufficient. Net reclassification improvement (NRI) offers a simple intuitive way of quantifying improvement offered by new markers and has been gaining popularity among researchers. However, several aspects of the NRI have not been studied in sufficient detail.

Subfields: Economics and Econometrics, Statistics and Probability

View Paper: https://www.semanticscholar.org/paper/cb8531867f895658de6ef62fa29ff989c391bff8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

  1. Gary S. Collins
  2. Karel G. M. Moons
  3. Johannes B Reitsma
  4. Douglas G. Altman
  5. Ewout W. Steyerberg
  6. Y. Vergouwe
  7. R. Riley
  8. Joris A. H. de Groot

In Statistics and Probability

  1. Karel G. M. Moons
  2. Gary S. Collins
  3. Douglas G. Altman
  4. Johannes B Reitsma
  5. Ewout W. Steyerberg
  6. Y. Vergouwe
  7. R. Riley
  8. Patrick Royston

Citations in the corpus